| Metric | Q2 2025 | Q1 2025 | Q2 2024 | QoQ Change | YoY Change |
|---|---|---|---|---|---|
| Revenue | $26M | $25M | $29M | 2.2% | -11.4% |
| Op. Income | $12M | -$52M | -$12M | 122.4% | 201.4% |
| Gross Margin | 48.6% | 49.1% | 47.6% | -0.4pp | 1.0pp |
| Net Margin | 58.0% | -229.9% | -41.3% | 287.8pp | 99.3pp |
| EPS (Diluted) | $0.07 | $-0.32 | $-0.09 | 122.2% | 179.1% |
| Free Cash Flow | -$64M | -$48M | -$15M | -35.6% | -342.1% |
| Item | Amount |
|---|---|
| REVENUE | $26M |
| Cost of Revenue | $13M |
| GROSS PROFIT | $12M |
| R&D Expenses | $0 |
| Selling & Marketing | $0 |
| General & Administrative | $20M |
| SG&A Expenses | $20M |
| Other Expenses | -$19M |
| Operating Expenses | $736.2K |
| Cost & Expenses | $14M |
| OPERATING INCOME | $12M |
| Interest Income | $337.9K |
| Interest Expense | $0 |
| Other Income/Expenses | $5M |
| INCOME BEFORE TAX | $16M |
| Income Tax Expense | $2M |
| Net Income from Continuing Ops | $15M |
| Net Income from Discontinued Ops | $0 |
| Other Adjustments | $0 |
| NET INCOME | $15M |
| Net Income Deductions | $0 |
| BOTTOM LINE NET INCOME | $15M |
| D&A | $8M |
| EBIT | -$15M |
| EBITDA | -$7M |
| EPS | $0 |
| EPS Diluted | $0 |
| Item | Amount |
|---|---|
| REVENUE | $26M |
| Cost of Revenue | $13M |
| GROSS PROFIT | $12M |
| R&D Expenses | $0 |
| Selling & Marketing | $0 |
| General & Administrative | $20M |
| SG&A Expenses | $20M |
| Other Expenses | -$19M |
| Operating Expenses | $736.2K |
| Cost & Expenses | $14M |
| OPERATING INCOME | $12M |
| Interest Income | $337.9K |
| Interest Expense | $0 |
| Other Income/Expenses | $5M |
| INCOME BEFORE TAX | $16M |
| Income Tax Expense | $2M |
| Net Income from Continuing Ops | $15M |
| Net Income from Discontinued Ops | $0 |
| Other Adjustments | $0 |
| NET INCOME | $15M |
| Net Income Deductions | $0 |
| BOTTOM LINE NET INCOME | $15M |
| D&A | $8M |
| EBIT | -$15M |
| EBITDA | -$7M |
| EPS | $0 |
| EPS Diluted | $0 |
| Item | Amount |
|---|---|
| Net Income | $15M |
| Depreciation & Amortization | $8M |
| Stock-Based Compensation | $7M |
| Deferred Income Tax | $0 |
| Other Non-Cash Items | -$37M |
| Change in Working Capital | $25M |
| OPERATING CASH FLOW | $18M |
| Capital Expenditure | -$82M |
| Acquisitions (Net) | $906.0K |
| Purchases of Investments | -$2M |
| Sales/Maturities of Investments | $0 |
| Other Investing Activities | $0 |
| NET CASH FROM INVESTING | -$83M |
| Net Debt Issuance | $0 |
| Common Stock Repurchased | $0 |
| Common Dividends Paid | $0 |
| Other Financing Activities | $0 |
| NET CASH FROM FINANCING | $190M |
| FREE CASH FLOW | -$64M |
| Net Change in Cash | $124M |
| Item | Amount |
|---|---|
| Cash & Equivalents | $181M |
| Short-Term Investments | $4M |
| Net Receivables | $16M |
| Inventory | $0 |
| Other Current Assets | $98M |
| TOTAL CURRENT ASSETS | $314M |
| PP&E (Net) | $320M |
| Goodwill | $20M |
| Intangible Assets | $13M |
| Long-Term Investments | $48M |
| Tax Assets | $93.0K |
| Other Non-Current Assets | $8M |
| TOTAL NON-CURRENT ASSETS | $410M |
| TOTAL ASSETS | $723M |
| Account Payables | $2M |
| Short-Term Debt | $0 |
| Deferred Revenue | $12M |
| Other Current Liabilities | $0 |
| TOTAL CURRENT LIABILITIES | $40M |
| Long-Term Debt | $0 |
| Deferred Revenue NC | $28.0K |
| Deferred Tax Liabilities | $8M |
| Other Non-Current Liabilities | $4M |
| TOTAL NON-CURRENT LIABILITIES | $50M |
| TOTAL LIABILITIES | $90M |
| Common Stock | $3M |
| Additional Paid-In Capital | $762M |
| Retained Earnings | -$141M |
| Treasury Stock | -$1M |
| Accum. Other Comp. Income | $1M |
| Other Equity | $0 |
| TOTAL STOCKHOLDERS' EQUITY | $633M |
| Minority Interest | $0 |
| TOTAL EQUITY | $633M |
| TOTAL LIABILITIES & EQUITY | $723M |
| Total Debt | $44M |
| Net Debt | -$137M |
